Table 2.

Leukocyte response to an acute bout of high-intensity interval training

Cell TypeType 2 DiabetesHealthy ControlsP Value
PrePost1-h PostPrePost1-h PostGroupTimeGroup × Time
Classical monocytes × 105/ml3.2 ± 0.404.5 ± 0.58*3.1 ± 0.29*#3.3 ± 0.834.2 ± 1.6*3.1 ± 0.92#0.63<0.0010.24
CD16+ monocytes × 105/ml0.18 ± 0.120.27 ± 0.19*0.18 ± 0.11#0.15 ± 0.080.17 ± 0.11*0.09 ± 0.04#0.30.0040.17
Neutrophils × 105/ml30.6 ± 6.244.1 ± 11.8*32.2 ± 5.8#25.3 ± 7.632.1 ± 11.2*24.4 ± 5.4#0.02<0.0010.21
Lymphocytes × 105/ml15.9 ± 4.228.0 ± 7.3*16.8 ± 4.7#15.6 ± 3.926.1 ± 10.4*15.1 ± 3.4#0.57<0.0010.64
CD16+ monocytes (% of total monocytes)4.5 ± 3.55.4 ± 3.75.3 ± 3.04.8 ± 2.44.3 ± 2.03.5 ± 1.80.480.620.08
Total leukocytes × 105/ml50.3 ± 7.975.1 ± 18.3*52.6 ± 8.3#42.8 ± 13.158.9 ± 18.6*43.5 ± 7.8#0.03<0.0010.77

Data are expressed as means ± SD. Type 2 diabetes: n = 5 males, n = 5 females. Healthy controls: n = 4 males, n = 5 females.

  • * Fisher least significant difference post hoc vs. Pre (time main effect, P < 0.05).

  • # Fisher post hoc vs. Post (time main effect, P < 0.05).